Technology

Center allows the commercial launch of the first CRISPR Covid-19 test | All you need to know

The Comptroller General of Drugs of India (DGCI) on Saturday approved the country’s first Covid-19 Clustered Regularly Interspaced Short Palindromic (CRISPR) test for commercial launch. This is developed by Tata and developed by CSIR-IGIB (Institute for Genomics and Integrative Biology) FELUDA (an acronym for FNCAS9 Editor-Limited Uniform Detection Assay). “The …

Read More »

Feluda, First Desi Covid Detector, Gets Regulator Approval | India News

NEW DELHI / MUMBAI: An indigenously developed test using state-of-the-art CRISPR gene editing technology to accurately, inexpensively and rapidly detect the SARS-CoV-2 virus that causes Covid-19 infection has been approved for its commercial launch by Drugs Comptroller General of India. Developed by scientists from IGIB (Institute for Genomics and Integrative …

Read More »

DCGI Approves Commercial Launch of Low-Cost Covid-19 ‘Feluda’ Test | India News

NEW DELHI: India’s Comptroller General of Drugs approved the commercial launch of ‘Feluda’, the Tata CRISPR (regularly interspaced regularly clustered short palindromic repeats) Covid-19 test, the Council for Scientific and Industrial Research (CSIR) said on Saturday. This test uses state-of-the-art CRISPR technology developed in the country for the detection of …

Read More »